Uterine carcinosarcomas (UCS) were the lineage with the greatest rates of genomic or transcript upregulation of MYLK2 and ACTG1, with Net Gain Scores of 0.21 and 0.14 respectively (Figure 1B and Figure 2A). The gene discussed is MYLK2; the disease is uterine carcinosarcoma.